{
    "b90b1ecc-a21f-36cd-bd78-9b73d99e6301": {
        "uuid": "b90b1ecc-a21f-36cd-bd78-9b73d99e6301",
        "title": "10 Best Vanguard Dividend Stocks with High Yields",
        "publisher": "Insider Monkey",
        "link": "https://finance.yahoo.com/news/10-best-vanguard-dividend-stocks-133955697.html",
        "providerPublishTime": 1652881195,
        "type": "STORY"
    },
    "3c589e4c-ca5e-3f69-b2c7-877c3398006b": {
        "uuid": "3c589e4c-ca5e-3f69-b2c7-877c3398006b",
        "title": "Vertex (VRTX) Outperforms Industry This Year So Far: Here's Why",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/vertex-vrtx-outperforms-industry-far-130601020.html",
        "providerPublishTime": 1652879161,
        "type": "STORY"
    },
    "0baf41df-c858-3cf0-ae79-fb24b6c6e02e": {
        "uuid": "0baf41df-c858-3cf0-ae79-fb24b6c6e02e",
        "title": "Buffett\u2019s Berkshire Hathaway is buying up Chevron, Citigroup, Paramount stocks",
        "publisher": "Yahoo Finance Video",
        "link": "https://finance.yahoo.com/video/buffett-berkshire-hathaway-buying-chevron-155829742.html",
        "providerPublishTime": 1652803109,
        "type": "VIDEO"
    },
    "31c3b7c4-7c2d-3c00-808b-68bc93ad9e6a": {
        "uuid": "31c3b7c4-7c2d-3c00-808b-68bc93ad9e6a",
        "title": "Is It Too Late to Buy AbbVie Stock?",
        "publisher": "Motley Fool",
        "link": "https://finance.yahoo.com/m/31c3b7c4-7c2d-3c00-808b-68bc93ad9e6a/is-it-too-late-to-buy-abbvie.html",
        "providerPublishTime": 1652800980,
        "type": "STORY"
    },
    "29c6d777-27ed-3a9d-825a-cba110f32a28": {
        "uuid": "29c6d777-27ed-3a9d-825a-cba110f32a28",
        "title": "AbbVie (ABBV) Buys Option Rights to NextGen Inflammation Drug",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/abbvie-abbv-buys-option-rights-132701108.html",
        "providerPublishTime": 1652794021,
        "type": "STORY"
    },
    "b22958a7-cb15-3ba5-8f44-811ef41379f1": {
        "uuid": "b22958a7-cb15-3ba5-8f44-811ef41379f1",
        "title": "Berkshire Hathaway exited Bristol Myers and AbbVie stakes in Q1",
        "publisher": "MarketWatch",
        "link": "https://finance.yahoo.com/m/b22958a7-cb15-3ba5-8f44-811ef41379f1/berkshire-hathaway-exited.html",
        "providerPublishTime": 1652737980,
        "type": "STORY"
    },
    "cc8420fe-01f8-3e0b-85b4-85ff830fff37": {
        "uuid": "cc8420fe-01f8-3e0b-85b4-85ff830fff37",
        "title": "Is AbbVie Stock A Buy As Humira Biosimilar Rivals Loom?",
        "publisher": "Investor's Business Daily",
        "link": "https://finance.yahoo.com/m/cc8420fe-01f8-3e0b-85b4-85ff830fff37/is-abbvie-stock-a-buy-as.html",
        "providerPublishTime": 1652732775,
        "type": "STORY"
    },
    "9d1b1a96-0821-3bf8-a4c1-07ffefa8a091": {
        "uuid": "9d1b1a96-0821-3bf8-a4c1-07ffefa8a091",
        "title": "AbbVie, Cugene Ink Licensing Pact For Autoimmune & Inflammatory Disease Candidate",
        "publisher": "Benzinga",
        "link": "https://finance.yahoo.com/news/abbvie-cugene-ink-licensing-pact-162719478.html",
        "providerPublishTime": 1652718439,
        "type": "STORY"
    }
}